These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18952352)

  • 21. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of neurological outcomes following witnessed out-of-hospital ventricular fibrillation defibrillated with either biphasic or monophasic automated external defibrillators.
    Kajino K; Iwami T; Berg RA; Hiraide A; Hayashi Y; Yukioka H; Tanaka H; Shimazu T; Sugimoto H
    Emerg Med J; 2009 Jul; 26(7):492-6. PubMed ID: 19546269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation.
    Lever NA; Newall EG; Larsen PD
    Europace; 2007 Nov; 9(11):1054-8. PubMed ID: 17872925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of chronaxies for ventricular fibrillation induction, defibrillation, and cardiac stimulation: unexpected findings and their implications.
    Lawo T; Deneke T; Schrader J; Danilovic D; Wenzel B; Buddensiek M; Muegge A
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):307-14. PubMed ID: 19175850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference?
    Turner I; Turner S; Grace AA
    Resuscitation; 2009 Feb; 80(2):183-8. PubMed ID: 19091453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undersensing of VF in a patient with optimal R wave sensing during sinus rhythm.
    Dekker LR; Schrama TA; Steinmetz FH; Tukkie R
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):833-4. PubMed ID: 15189548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of nonlinear heart rate dynamics after beating-heart revascularization.
    Ksela J; Suwalski P; Kalisnik JM; Avbelj V; Suwalski G; Gersak B
    Heart Surg Forum; 2009 Jan; 12(1):E10-6. PubMed ID: 19233759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable cardioverter-defibrillator shocks increase T-wave alternans.
    Lampert R; Soufer R; McPherson CA; Batsford WP; Tirado S; Earley C; Goldberg A; Shusterman V
    J Cardiovasc Electrophysiol; 2007 May; 18(5):512-7. PubMed ID: 17428273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
    Maeda K; Takagi M; Tatsumi H; Nakagawa E; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):11-9. PubMed ID: 18819261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impedance cardiogram recorded through two electrocardiogram/defibrillator pads as a determinant of cardiac arrest during experimental studies.
    Cromie NA; Allen JD; Turner C; Anderson JM; Adgey AA
    Crit Care Med; 2008 May; 36(5):1578-84. PubMed ID: 18434896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography.
    Runsiö M; Bergfeldt L; Brodin LA; Ribeiro A; Samuelsson S; Rosenqvist M
    Eur Heart J; 1997 Jan; 18(1):124-31. PubMed ID: 9049524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of ventricular defibrillation.
    Pansegrau DG; Abboud FM
    J Clin Invest; 1970 Feb; 49(2):282-97. PubMed ID: 4904240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the ventricular fibrillation waveform in refibrillation.
    Russell JK; White RD; Crone WE
    Crit Care Med; 2006 Dec; 34(12 Suppl):S432-7. PubMed ID: 17114973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defibrillation and the upper limit of vulnerability to fibrillation in a transthoracic guinea pig model.
    Li H; Malkin RA
    J Electrocardiol; 1999 Apr; 32(2):159-66. PubMed ID: 10338034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency analysis of ventricular fibrillation and resuscitation success.
    Stewart AJ; Allen JD; Adgey AA
    Q J Med; 1992 Oct; 85(306):761-9. PubMed ID: 1287707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M; Videbaek R; Boesgaard S; Sander K; Hansen PB; Gustafsson F
    J Heart Lung Transplant; 2009 Jul; 28(7):733-5. PubMed ID: 19560703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.